Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SALMETEROL vs SARILUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SALMETEROL vs SARILUMAB: Safety Overview

Metric SALMETEROL SARILUMAB
Total FAERS Reports 1,761 21,493
Deaths Reported 263 1,983
Death Rate 14.9% 9.2%
Hospitalizations 487 3,538
Average Patient Age 65.5 yrs 57.5 yrs
% Female Patients 68.4% 84.4%
FDA Approval Date Feb 4, 1994 N/A
Manufacturer GlaxoSmithKline LLC Sanofi-Aventis U.S. LLC
Route ORAL SUBCUTANEOUS
Marketing Status Discontinued Prescription